NASDAQ:CBUS Cibus (CBUS) Stock Price, News & Analysis → It's time to ween off Chinese lithium! (From Smallcaps Daily) (Ad) Free CBUS Stock Alerts $10.83 -0.01 (-0.09%) (As of 10:49 AM ET) Add Compare Share Share Today's Range$10.83▼$11.1350-Day Range$10.84▼$20.6552-Week Range$8.90▼$24.61Volume18,106 shsAverage Volume69,122 shsMarket Capitalization$233.39 millionP/E RatioN/ADividend YieldN/APrice Target$25.00 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Get Cibus alerts: Email Address Cibus MarketRank™ Stock AnalysisAnalyst RatingBuy3.00 Rating ScoreUpside/Downside130.6% Upside$25.00 Price TargetShort InterestBearish4.26% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment0.00Based on 7 Articles This WeekInsider TradingN/AProj. Earnings GrowthGrowingFrom ($3.22) to ($2.35) Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.1.44 out of 5 starsConsumer Staples Sector110th out of 127 stocksAgricultural Chemicals Industry9th out of 9 stocks 3.5 Analyst's Opinion Consensus RatingCibus has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.Amount of Analyst CoverageCibus has only been the subject of 1 research reports in the past 90 days.Read more about Cibus' stock forecast and price target. Previous Next 2.0 Short Interest Percentage of Shares Shorted4.26% of the float of Cibus has been sold short.Short Interest Ratio / Days to CoverCibus has a short interest ratio ("days to cover") of 8.9.Change versus previous monthShort interest in Cibus has recently increased by 31.84%, indicating that investor sentiment is decreasing significantly. Previous Next 0.0 Dividend Strength Dividend YieldCibus does not currently pay a dividend.Dividend GrowthCibus does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for CBUS. Previous Next 0.0 News and Social Media Coverage News Coverage This WeekMarketBeat has tracked 7 news articles for Cibus this week, compared to 1 article on an average week. Previous Next 1.7 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Cibus insiders have not sold or bought any company stock.Percentage Held by Insiders49.40% of the stock of Cibus is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by InstitutionsOnly 33.81% of the stock of Cibus is held by institutions.Read more about Cibus' insider trading history. Previous Next 1.3 Earnings and Valuation Earnings GrowthEarnings for Cibus are expected to grow in the coming year, from ($3.22) to ($2.35) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Cibus is -0.59, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Cibus is -0.59, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioCibus has a P/B Ratio of 0.88. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.Read more about Cibus' valuation and earnings. Previous Next See Top Rated MarketRank™ Stocks Here Ad Smallcaps DailyIt's time to ween off Chinese lithium!As the lithium rush continues, this small-cap NASDAQ-traded company may be one of the brightest and most promising companies to be watching closelyLearn how this American company is leading the lithium-ion revolution About Cibus Stock (NASDAQ:CBUS)Cibus, Inc., a agricultural biotechnology company, develops and licenses plant traits to seed companies for royalties. The company primarily focus on trait productivity in two areas, including productivity traits that enable farmers to have higher yields and reduce the use of the crop protection chemicals and fertilizers; and sustainable ingredients that enable corporations to replace ingredients that are fossil fuel based or whose production results in increased greenhouse gases. Cibus, Inc. is based in San Diego, California.Read More CBUS Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart CBUS Stock News HeadlinesJune 6, 2024 | globenewswire.comCIBUS ALERT: Bragar Eagel & Squire, P.C. is Investigating Cibus, Inc. on Behalf of Cibus Stockholders and Encourages Investors to Contact the FirmJune 6, 2024 | globenewswire.comSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Cibus, Inc. - CBUSJune 5, 2024 | globenewswire.comInvestigation Into Cibus, Inc. (CBUS) Announced by Holzer & Holzer, LLCJune 5, 2024 | globenewswire.comCibus to Participate in Upcoming June Investor EventsJune 4, 2024 | businesswire.comINVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Cibus, Inc. (CBUS) on Behalf of InvestorsJune 4, 2024 | globenewswire.comCibus Investigated For Securities Fraud; Block & Leviton Encourages Investors Who Have Lost Money to Contact the FirmJune 4, 2024 | globenewswire.comBreaking News: Johnson Fistel, LLP Investigates Cibus Following Short ReportMay 16, 2024 | finance.yahoo.comCibus, Inc. (CBUS)May 15, 2024 | finance.yahoo.comCanada Added to a Growing List of Countries Regulating Cibus’ Gene Editing Technologies Similar to Conventional BreedingMay 15, 2024 | globenewswire.comCanada Added to a Growing List of Countries Regulating Cibus' Gene Editing Technologies Similar to Conventional BreedingMay 13, 2024 | msn.comCibus, Inc. (NASDAQ:CBUS) Q1 2024 Earnings Call TranscriptMay 13, 2024 | finance.yahoo.comCibus to Participate in the BMO Global Farm to Market ConferenceMay 10, 2024 | markets.businessinsider.comCibus’ Promising Developments and Financial Stability Bolster Buy RatingMay 10, 2024 | markets.businessinsider.comCibus Reports Q1 Loss, Tops Revenue EstimatesMay 10, 2024 | investorplace.comCBUS Stock Earnings: Cibus Misses EPS, Beats Revenue for Q1 2024May 9, 2024 | finance.yahoo.comCibus Reports First Quarter Financial Results and Provides Business UpdateMay 5, 2024 | morningstar.comCibus Inc Ordinary Shares - Class A CBUSMay 3, 2024 | finance.yahoo.comCibus, Inc.'s (NASDAQ:CBUS) top owners are individual investors with 53% stake, while 26% is held by institutionsApril 25, 2024 | globenewswire.comCibus to Report First Quarter 2024 Financial Results on May 9, 2024 and Host Conference CallMarch 23, 2024 | finance.yahoo.comCibus Full Year 2023 Earnings: Revenues Beat Expectations, EPS LagsMarch 22, 2024 | markets.businessinsider.comCibus’s Market Potential and Advancements Justify Buy RatingMarch 22, 2024 | insidermonkey.comCibus, Inc. (NASDAQ:CBUS) Q4 2023 Earnings Call TranscriptMarch 21, 2024 | investorplace.comCBUS Stock Earnings: Cibus Beats EPS, Beats Revenue for Q4 2023March 21, 2024 | stockhouse.comCibus Named to Fast Company's Annual List of the World's Most Innovative Companies of 2024March 21, 2024 | finance.yahoo.comCibus Inc (CBUS) Reports Q4 Financial Results and Business DevelopmentsSee More Headlines Receive CBUS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Cibus and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings5/09/2024Today6/10/2024Next Earnings (Estimated)8/14/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorConsumer Staples Industry Agricultural chemicals Sub-IndustryN/A Current SymbolNASDAQ:CBUS CUSIPN/A CIK1705843 Webwww.calyxt.com Phone(858) 450-0008FaxN/AEmployees183Year FoundedN/APrice Target and Rating Average Stock Price Target$25.00 High Stock Price Target$25.00 Low Stock Price Target$25.00 Potential Upside/Downside+130.6%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage1 Analysts Profitability EPS (Most Recent Fiscal Year)($18.35) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-267,640,000.00 Net Margins-12,313.28% Pretax Margin-15,483.06% Return on Equity-23.33% Return on Assets-13.19% Debt Debt-to-Equity RatioN/A Current Ratio1.23 Quick Ratio1.23 Sales & Book Value Annual Sales$1.82 million Price / Sales128.35 Cash Flow$7.74 per share Price / Cash Flow1.40 Book Value$12.38 per share Price / Book0.88Miscellaneous Outstanding Shares21,550,000Free Float10,902,000Market Cap$233.60 million OptionableOptionable Beta1.92 20 Stocks to Sell NowMarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.Get This Free Report Key ExecutivesMr. Rory Balfour Riggs M.B.A. (Age 71)Co-Founder, CEO & Chairman Dr. Peter Beetham B.Sc. (Age 61)Ph.D., Co-Founder, President, COO & Director Dr. Greg Gocal Ph.D. (Age 55)Co-Founder, Chief Scientific Officer & Executive VP Dr. Wade Hampton King (Age 66)Chief Financial Officer Mr. Steve BerrethGeneral Counsel & Corporate SecretaryMs. Rosa Cheuk Kim J.D.Senior Vice President of LegalDr. James Radtke Ph.D.Senior Vice President of Product DevelopmentMr. Tony MoranSenior Vice President of International DevelopmentNorm SissonsSenior Vice President of Seed & TraitsMs. Noel Sauer Ph.D.Senior Vice President of ResearchMore ExecutivesKey CompetitorsMarrone Bio InnovationsNASDAQ:MBIILifeVantageNASDAQ:LFVNNatural Alternatives InternationalNASDAQ:NAIIMannatechNASDAQ:MTEXBioceres Crop SolutionsNASDAQ:BIOXView All CompetitorsInsiders & InstitutionsVanguard Group Inc.Bought 26,017 shares on 5/10/2024Ownership: 3.339%Rory B RiggsBought 517,107 shares on 12/12/2023Total: $5.47 M ($10.58/share)View All Insider TransactionsView All Institutional Transactions CBUS Stock Analysis - Frequently Asked Questions Should I buy or sell Cibus stock right now? 1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Cibus in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "buy" CBUS shares. View CBUS analyst ratings or view top-rated stocks. What is Cibus' stock price target for 2024? 1 Wall Street analysts have issued twelve-month price targets for Cibus' stock. Their CBUS share price targets range from $25.00 to $25.00. On average, they expect the company's share price to reach $25.00 in the next twelve months. This suggests a possible upside of 130.6% from the stock's current price. View analysts price targets for CBUS or view top-rated stocks among Wall Street analysts. How have CBUS shares performed in 2024? Cibus' stock was trading at $19.64 at the beginning of the year. Since then, CBUS shares have decreased by 44.8% and is now trading at $10.84. View the best growth stocks for 2024 here. Are investors shorting Cibus? Cibus saw a increase in short interest during the month of May. As of May 15th, there was short interest totaling 610,400 shares, an increase of 31.8% from the April 30th total of 463,000 shares. Based on an average trading volume of 68,800 shares, the short-interest ratio is presently 8.9 days. Approximately 4.3% of the company's shares are sold short. View Cibus' Short Interest. When is Cibus' next earnings date? The company is scheduled to release its next quarterly earnings announcement on Wednesday, August 14th 2024. View our CBUS earnings forecast. How were Cibus' earnings last quarter? Cibus, Inc. (NASDAQ:CBUS) issued its quarterly earnings data on Thursday, May, 9th. The company reported ($1.12) earnings per share (EPS) for the quarter, missing the consensus estimate of ($1.01) by $0.11. The business had revenue of $0.55 million for the quarter, compared to analyst estimates of $0.40 million. Cibus had a negative net margin of 12,313.28% and a negative trailing twelve-month return on equity of 23.33%. During the same quarter last year, the company posted ($5.45) earnings per share. When did Cibus IPO? Cibus (CBUS) raised $100 million in an initial public offering (IPO) on Thursday, February 14th 2019. The company issued 6,700,000 shares at a price of $14.00-$16.00 per share. Morgan Stanley, BofA Merrill Lynch and Piper Jaffray acted as the underwriters for the IPO. Who are Cibus' major shareholders? Cibus' stock is owned by a number of institutional and retail investors. Top institutional investors include Vanguard Group Inc. (3.34%). View institutional ownership trends. How do I buy shares of Cibus? Shares of CBUS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:CBUS) was last updated on 6/10/2024 by MarketBeat.com Staff From Our PartnersAI's Next Magnificent SevenThe Original Magnificent Seven Produced 16,894% Average Returns Over 20 Years.The Oxford Club | SponsoredTrump convicted... now what?Unexpected Twist to Trump's Trial Most folks sense there's more to the Trump trial than meets the eye. B...Stansberry Research | SponsoredIt's time to ween off Chinese lithium!As the lithium rush continues, this small-cap NASDAQ-traded company may be one of the brightest and most promi...Smallcaps Daily | SponsoredTime is Running Out - June 25th Deadline Approaching!Today, I’m making my boldest prediction ever. Next-generation AI technology will create the first $100 TRIL...Paradigm Press | SponsoredTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredTop 5 AI Stocks to Buy for 2024The electric vehicle boom is accelerating – and fast.Market Moving Trends | SponsoredNo Strings Attached: Get 30 Days of Hedgeye’s Top Stock Picks for FreeOptimize your stock investing strategy with Hedgeye's Investing Ideas, where rigorous fundamental stock analys...Hedgeye | SponsoredThe Only Energy Play You Should Be Looking AtOpen AI’s Sam Altman recently helped this company raise $577 million in funding… What’s more is, It has alr...Wealthpin Pro | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cibus, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cibus With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
